Clinical Trial: Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver

Study Status: No longer available
Recruit Status: No longer available
Study Type: Expanded Access

Official Title: An Open Label, Expanded Access Study of Melphalan Chemosaturation With the Delcath System in Patients With Ocular and Cutaneous Melanoma Metastatic to the Liver

Brief Summary: The safety and efficacy of CS-PHP-melphalan has been evaluated in a phase 3 trial conducted in the same patient population as well as using the same melphalan dosing as proposed in this study. This expanded access protocol will provide an experimental alternative treatment option for both physicians and patients until the Delcath CS-PHP System receives marketing approval.

Detailed Summary:
Sponsor: Delcath Systems Inc.

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Delcath Systems Inc.

Dates:
Date Received: November 13, 2012
Date Started:
Date Completion:
Last Updated: October 22, 2013
Last Verified: October 2013